Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies produced in rabbits.

Journal of neuroimmunology | 2009

N-truncated and N-modified forms of amyloid beta (Abeta) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) and Down's syndrome patients as well as transgenic mouse models of AD. Although the pathological significance of these shortened forms Abeta is not completely understood, previous studies have demonstrated that these peptides are significantly more resistant to degradation, aggregate more rapidly in vitro and exhibit similar or, in some cases, increased toxicity in hippocampal neuronal cultures compared to the full length peptides. In the present study we further investigated the mechanisms of toxicity of one of the most abundant N-truncated/modified Abeta peptide bearing amino-terminal pyroglutamate at position 3 (AbetaN3(pE)). We demonstrated that AbetaN3(pE) oligomers induce phosphatidyl serine externalization and membrane damage in SH-SY5Y cells. Also, we produced AbetaN3(pE)-specific polyclonal antibodies in rabbit and identified an immunodominant epitope recognized by anti-AbetaN3(pE) antibodies. Our results are important for developing new immunotherapeutic compounds specifically targeting AbetaN3(pE) aggregates since the most commonly used immunogens in the majority of vaccines for AD have been shown to induce antibodies that recognize the N-terminal immunodominant epitope (EFRH) of the full length Abeta, which is absent in N-amino truncated peptides.

Pubmed ID: 19545911 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241-05
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS050895-03
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241-01
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS050895-06
  • Agency: NIA NIH HHS, United States
    Id: P50 AG16573
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS050895-04
  • Agency: NIA NIH HHS, United States
    Id: P50 AG016573
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241-03
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS050895-05
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241-08
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS050895-02
  • Agency: NIA NIH HHS, United States
    Id: NIA AG20241
  • Agency: NINDS NIH HHS, United States
    Id: NINDS NS50895
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241-06
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241-02S1
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241-04
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241-07
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS050895-01A1
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020241-02
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS050895

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BLASTP (tool)

RRID:SCR_001010

Data analysis service whose programs search protein databases using a protein query. The algorithms used include blastp, psi-blast, phi-blast, and delta-blast.

View all literature mentions

Imaris (tool)

RRID:SCR_007370

Imaris provides range of capabilities for working with three dimensional images. Uses flexible editing and processing functions, such as interactive surface rendering and object slicing capabilities. And output to standard TIFF, Quicktime and AVI formats. Imaris accepts virtually all image formats that are used in confocal microscopy and many of those used in wide-field image acquisition.

View all literature mentions